SAM
ANIP icon

Smartleaf Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Smartleaf Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.04K Hold
48
– – ﹤0.01% 2751
2026
Q1 		$3.54K Sell
48
-155
-76% -$12.1K ﹤0.01% 2789
2025
Q4 		$16.1K Hold
203
– – ﹤0.01% 2152
2025
Q3 		$18.7K Sell
203
-8
-4% -$652 ﹤0.01% 1839
2025
Q2 		$13.8K Sell
211
-2
-0.9% -$130 ﹤0.01% 1708
2025
Q1 		$14.4K Sell
213
-13
-6% -$776 ﹤0.01% 1769
2024
Q4 		$12.3K Buy
226
+184
+438% +$10.6K ﹤0.01% 1909
2024
Q3 		$2.47K Buy
42
+17
+68% +$1.04K ﹤0.01% 2412
2024
Q2 		$1.58K Buy
+25
New +$1.62K ﹤0.01% 2307

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's ANIP Position: Q2 2026 in Review

Smartleaf Asset Management held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 48 shares worth $4.04K. The position accounts for ﹤0.01% of the portfolio, ranked #2751.

Smartleaf Asset Management first reported a position in ANIP in Q2 2024 and has held it in 9 quarters since. The position peaked at $18.7K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Smartleaf Asset Management held 48 shares of ANI Pharmaceuticals worth $4.04K as of Q2 2026.
  • Smartleaf Asset Management left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2751 holding.
  • Smartleaf Asset Management first reported a position in ANI Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's ANI Pharmaceuticals position peaked at $18.7K in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.